The Education and Information Transfer Core provides both training in basic science and clinical aspects of Alzheimer's disease, and information transfer within the ADRC, to health professional in the community, to caregivers and individuals affected by the disease, and to the general public. This includes providing cutting edge research training, professional staff enrichment, fostering interest in AD especially in under-represented groups, and providing information about our ADRC and its clinical research programs. We will also reach out to caregivers and individuals affected by AD to provide them with information, support groups, access to community resources, and opportunities to participate in research.
Four specific aims will accomplish these goals: 1) Support the development of scientists, physicians, and other professional staff to improve research and clinical skills. This will be done at the basic science level through affiliated graduate programs, seminar series, and our pilot research program. At the clinical level, it will be accomplished through our biweekly clinical meetings, the mini-residency program, courses/lectures taught by our faculty, and dementia and geriatric fellowships. 2) Enhance the knowledge about AD diagnosis, care, and research in community healthcare providers. Activities include our annual CME conference, the mini-residency program, and numerous seminars and in-service training about research advances, diagnosis and management of AD.3) Enhance recruitment of under-represented groups into AD research and care through the development of culturally sensitive recruitment strategies and patient care program for Hispanics. A special attempt is made to educate the Hispanic community, including both healthcare professionals and the general public regarding diagnosis, care and the management of AD. We also strive to increase participation in research. 4) Increase public knowledge of AD, including information for caregivers, and promote recruitment into AD clinical research programs. We work closely with the San Diego Chapter of the Alzheimer's Association and other groups in San Diego to sponsor educational activities like our Young Caregiver and Patient Support groups. We also host an ADRC website with current information on the disease, produce a newsletter, and host an annual Fall Open House for participants and their families.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005131-25
Application #
7591072
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
25
Fiscal Year
2008
Total Cost
$169,465
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Graves, Lisa V; Holden, Heather M; Van Etten, Emily J et al. (2018) New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-3: Clinical Utility in Alzheimer's and Huntington's Disease. J Int Neuropsychol Soc 24:833-841
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Fong, Lauren K; Yang, Max M; Dos Santos Chaves, Rodrigo et al. (2018) Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-? clearance in human astrocytes. J Biol Chem 293:11341-11357
Edmonds, Emily C; Ard, M Colin; Edland, Steven D et al. (2018) Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study. Alzheimers Dement (N Y) 4:11-18
Spencer, Brian; Brüschweiler, Sven; Sealey-Cardona, Marco et al. (2018) Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders. Acta Neuropathol 136:69-87
Pottier, Cyril; Zhou, Xiaolai; Perkerson 3rd, Ralph B et al. (2018) Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol 17:548-558
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194

Showing the most recent 10 out of 914 publications